2024-02-04 06:16:00 ET
Summary
- Sports equipment and apparel maker Amer Sports priced below the range to raise $1.3 billion at a $6.4 billion market cap.
- CNS disorder biotech Alto Neuroscience priced its upsized IPO at the top of the range to raise $129 million at a $456 million market cap.
- Diabetes and obesity-focused Fractyl Health priced at the midpoint to raise $110 million at an $810 million market cap.
- Cell therapy biotech FibroBiologics completed its direct listing on the Nasdaq, opening 275% above its reference price to begin trading at $30.
Several large issuers debuted in the US this past week, and four IPOs joined the pipeline....
Read the full article on Seeking Alpha
For further details see:
U.S. IPO Weekly Recap: Amer Sports' Billion-Dollar U.S. IPO Leads A Week Of Large Listings